Psycho-Babble Neurotransmitters | advanced medication issues | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

differing cannbanoid effects TCA/SSRI

Posted by linkadge on March 19, 2010, at 6:55:29 [reposted on March 23, 2010, at 0:34:55 | original URL]

The antidepressant citalopram decreases cb1 cannabanoid function while the tricyclic antidepressants appear to increase it.

http://www.springerlink.com/content/2127100x043n3674/

Conclusions These data provide evidence for reduced cannabinoid receptor-mediated G-protein coupling in the hypothalamus, hippocampus and medial geniculate nucleus of rats chronically treated with citalopram, effects which may, in part, underlie the mechanism of action of SSRIs.

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=219

Three-week administration of the tricyclic antidepressant desipramine resulted in a significant increase in the density of CB1 receptors in certain brain areas (hippocampus and hypothalamus) without significantly altering endocannabinoid levels. The reduction of stress-induced corticosterone secretion by the antidepressant was blocked by a CB1 receptor antagonist

Linkadge


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Neurotransmitters | Framed

poster:linkadge thread:940505
URL: http://www.dr-bob.org/babble/neuro/20100223/msgs/940505.html